In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Russia Ukraine War: Russian-backed separatists in Eastern Ukraine have claimed that at least 53 U
Haryana Chief Minister Manohar Lal made a big announcement in Bhiwani on Tuesday. In the state-le
Uttar Pradesh Board of Secondary Education is going to release the date sheet for the 10th and 12
There will be a tough contest between the two heroines in the Hooghly Lok Sabha seat of West Beng
West Bengal SSC Scam: The problems of West Bengal Minister Partha Chatterjee are increasing. The
Amid the Delhi Assembly elections, the troubles of Aam Aadmi Party convener Arvind Kejriwal and f
The first of the year and the world's largest electronics show i.e. Consumer Electronics Show (CE
There was a ruckus in the Rajya Sabha on Wednesday during the discussion on the Constitution Amen
Today, on the occasion of Constitution Day, President Draupadi Murmu addressed the joint session
The court has delivered its verdict on five serious charges against former Bangladesh Prime Minis
